Clinical Trials in Atlanta

Showing 10041-10060 of 19,805 trials

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

NCT00089466

New treatment options are critical for treatment-experienced HIV infected patients with drug resistance. HIV entry inhibitors have been shown effective in patients with resistance to other anti-HIV drugs. This study will test the safety and anti-HIV activity of eight different doses of the HIV entry inhibitor AMD11070 (also known as AMD070) in HIV infected patients.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)6 participantsStarted Nov 2004

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Indianapolis, Indiana, United States

COMPLETEDPhase 4< 1 mile

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease

NCT01018264

This study will assess the effectiveness of solifenacin succinate (VESIcare) in reducing symptoms of overactive bladder in Parkinson's disease (PD) patients.

Overactive Bladder in Parkinson's Disease

University of South Florida23 participantsStarted Jan 2010

Miami, Florida, United States • Tampa, Florida, United States • Atlanta, Georgia, United States

COMPLETEDPhase 2/3< 1 mile

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

NCT03452943

This is a study to evaluate the efficacy and safety of deutetrabenazine (TEV-50717) tablets for the reduction of motor and phonic tics associated with TS in children and adolescents 6 through 16 years of age.

Tourette Syndrome

Teva Branded Pharmaceutical Products R&D, Inc.119 participantsStarted Feb 2018

Dothan, Alabama, United States • Sun City, Arizona, United States • Rogers, Arkansas, United States +39 more locations

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

Find Trials by Condition in Atlanta

A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Aim to Reduce Movements in Tardive Dyskinesia

Addressing Barriers to Adult Hearing Healthcare

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

A Study to Assess Indices of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19